Hackensack Meridian Health's endocrinology team is working to bring advanced diabetes care closer to home for the state's 693 ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

People with type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a ...

Fact checked by Jennifer Klump Key Takeaways Insulin costs have declined over the past two years, and additional price cuts ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of Pittsburgh researchers reported.

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating disease.

Adult and pediatric experts from @HopkinsMedicine, @EndoHopkins, and @HopkinsKids are available all month to raise diabetes awareness and discuss how the disease impacts adults and children.

A little-known desert berry may hold the key to fighting diabetes. Scientists may have uncovered a surprising new weapon in the fight against diabetes: the fruit of an ancient desert plant. Known as ...